Myoblox Contra Capsules 56ct Bottle UPC CODE 8 50001 91230 3
Reported: January 19, 2022 Initiated: November 9, 2021 #F-0467-2022
Product Description
Myoblox Contra Capsules 56ct Bottle UPC CODE 8 50001 91230 3
Reason for Recall
During an FDA investigation the firm was notified that the product contains undeclared milk.
Details
- Recalling Firm
- NutraCap Labs LLC
- Units Affected
- 80,169 various bottles and jars
- Distribution
- Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KY, LA, MD, MN, NC, NJ, NV, NY, OH, OR, SC, TN, TX, VA & WA.
- Location
- Norcross, GA
Frequently Asked Questions
What product was recalled? ▼
Myoblox Contra Capsules 56ct Bottle UPC CODE 8 50001 91230 3. Recalled by NutraCap Labs LLC. Units affected: 80,169 various bottles and jars.
Why was this product recalled? ▼
During an FDA investigation the firm was notified that the product contains undeclared milk.
Which agency issued this recall? ▼
This recall was issued by the FDA Food on January 19, 2022. Severity: Critical. Recall number: F-0467-2022.
Related Recalls
FDA Drug Moderate
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…
Unichem Pharmaceuticals USA Inc. · 2026-02-11
FDA Drug Critical
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San…
Green Lumber Holdings, LLC · 2026-02-11
FDA Drug Moderate
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500…
Granules Pharmaceuticals Inc. · 2026-02-11
FDA Drug Critical
Diclofenac Sodium, Topical Gel, 3%, 100 g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1…
SUN PHARMACEUTICAL INDUSTRIES INC · 2026-02-11
FDA Drug Critical
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India UPC 8 904218 700313
HANDELNINE GLOBAL LLC · 2026-02-11